2,811
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)

, , , , ORCID Icon, & show all
Article: 2280113 | Received 11 Jul 2023, Accepted 31 Oct 2023, Published online: 10 Nov 2023

References

  • Docter, S, Khan, M, Gohal, C, et al. Cannabis use and sport: a systematic review. Sports Health. 2020;12(2):189–945. doi: 10.1177/1941738120901670
  • Kasper, AM, Sparks, SA, Hooks, M, et al. High prevalence of cannabidiol use with in male professional rugby union and league players: a quest for pain relief and enhanced recovery. Int J Sport Nutr Exerc Metab. 2020;30(5):315–322. doi: 10.1123/ijsnem.2020-0151
  • YorkWilliams, SL, Gust, CJ, Mueller, R, et al. The new runner’s high? Examining relationships between cannabis use and exercise behavior in states with legalized cannabis. Front Public Health. 2019;7:99. doi: 10.3389/fpubh.2019.00099
  • An, D, Peigneur, S, Hendrickx, LA, et al. Targeting cannabinoid receptors: Current status and prospects of natural products. Int J Mol Sci. 2020;21(14):5064. doi: 10.3390/ijms21145064
  • Ibeas Bih, C, Chen, T, Nunn, AV, et al. Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics. 2015;12(4):699–730. doi: 10.1007/s13311-015-0377-3
  • McCartney, D, Benson, MJ, Desbrow, B, et al. Cannabidiol and sports performance: a narrative review of relevant evidence and recommendations for future research. Sports Med - Open. 2020;6(1):27. doi: 10.1186/s40798-020-00251-0
  • Hatchett, A, Armstrong, K, Hughes, B, et al. The influence cannabidiol on delayed onset of muscle soreness. Int J Phys Educ Sport Health. 2020;7(2):89–94.
  • Isenmann, E, Veit, S, Starke, L, et al. Effects of cannabidiol supplementation on skeletal muscle regeneration after intensive resistance training. Nutrients. 2021;13(9):3028. doi: 10.3390/nu13093028
  • Sahinovic, A, Irwin, C, Doohan, PT, et al. Effects of cannabidiol on exercise physiology and bioenergetics: a randomised controlled pilot trial. Sports Med - Open. 2022;8(1):27. doi: 10.1186/s40798-022-00417-y
  • Cochrane-Snyman, KC, Cruz, C, Morales, J, et al. The effects of cannabidiol oil on noninvasive measures of muscle damage in men. Med Sci Sports Exerc. 2021;53(7):1460–1472. doi: 10.1249/MSS.0000000000002606
  • Gertsch, J, Pertwee, RG, Di Marzo, V. Phytocannabinoids beyond the cannabis plant - do they exist? Br J Pharmacol. 2010;160(3):523–529. doi: 10.1111/j.1476-5381.2010.00745.x
  • Pertwee, RG, Howlett, AC, Abood, ME, et al. International union of basic and clinical pharmacology. LXXIX. cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev. 2010;62(4):588 631. doi: 10.1124/pr.110.003004
  • Petrocellis, LD, Marzo, VD. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J Neuroimmune Pharm. 2010;5(1):103 121. doi: 10.1007/s11481-009-9177-z
  • Banerjee, SP, Snyder, SH, Mechoulam, R. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. J Pharmacol Exper Ther. 1975;194(1):74 81.
  • Kaufmann, R. Nano-processed CBG/CBD effect on pain, adult attention deficit hyperactive disorder, irritable bowel syndrome and chronic fatigue syndrome. Int J Complement Alt Med. 2021;14(6):235–240. doi: 10.15406/ijcam.2021.14.00567
  • Russo, EB, Cuttler, C, Cooper, ZD, et al. Survey of patients employing cannabigerol-predominant cannabis preparations: perceived medical effects, adverse events, and withdrawal symptoms. Cannabis Cannabinoid Res. 2022;7(5):706–716. doi: 10.1089/can.2021.0058
  • Gertsch, J, Leonti, M, Raduner, S, et al. Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A. 2008;105(26):9099–9104. doi: 10.1073/pnas.0803601105
  • Shim, HI, Song, DJ, Shin, CM, et al. Inhibitory effects of β-caryophyllene on helicobacter pylori infection: a randomized double-blind, placebo-controlled study. Korean J Gastroenterol. 2019 Oct 25;74(4):199–204. doi: 10.4166/kjg.2019.74.4.199
  • Blanton, H, Yin, L, Duong, J, et al. Cannabidiol and beta-caryophyllene in combination: a therapeutic functional interaction. Int J Mol Sci. 2022;23(24):15470. doi: 10.3390/ijms232415470
  • Martinho, DV, Nobari, H, Faria, A, et al. Oral branched-chain amino acids supplementation in athletes: a systematic review. Nutrients. 2022 Sep 27;14(19):4002. doi: 10.3390/nu14194002
  • Steward, CJ, Zhou, Y, Keane, G, et al. One week of magnesium supplementation lowers IL-6, muscle soreness and increases post-exercise blood glucose in response to downhill running. Eur J Appl Physiol. 2019 Dec;119(11–12):2617–2627. doi: 10.1007/s00421-019-04238-y
  • Smith, RT, Gruber, SA. Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions. Front Psychiatry. 2023;13:1055481. doi: 10.3389/fpsyt.2022.1055481
  • Bae, S-H, Lee, Y-S, Kim, G-D, et al. The effects of kinesio-taping applied to delayed onset muscle soreness on changes in pain. Int J Bio-Sci Bio-Technol. 2014;6(3):133–142. doi: 10.14257/ijbsbt.2014.6.3.16
  • Food standards agency. Cannabidiol (CBD). Accessed February 18, 2023. https://www.food.gov.uk/safety-hygiene/cannabidiol-cbd.
  • Brierley, DI, Harman, JR, Giallourou, N, et al. Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol. J Cachexia Sarcopenia Muscle. 2019;10(4):844–859. doi: 10.1002/jcsm.12426
  • O’Brien, LD, Wills, KL, Segsworth, B, et al. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. Pharmacol Biochem Behav. 2013;103(3):597–602. doi: 10.1016/j.pbb.2012.10.008
  • Oliveira, GLDS, Machado, KC, Machado, KC, et al. Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: absence of adverse effects in female Swiss mice. Regul Toxicol Pharmacol. 2018;92:338–346. doi: 10.1016/j.yrtph.2017.12.013
  • Okazaki, S, Hatakeyama, K, Tamura, K, et al. (A). Acute and subacute toxicity study of BCAA-G in rats (in Japanese). Clin Rep. 1989;23:1843–1862.
  • Okazaki, S, Hatakeyama, K, Tamura, K, et al. (B). Chronic toxicity study of BCAA-G in rats (in Japanese). Clin Rep. 1989;23:1863–1903.
  • Frusso, R, Zárate, M, Augustovski, F, et al. Magnesium for the treatment of nocturnal leg cramps: a crossover randomized trial. J Fam Pract. 1999;48(11):868–871.
  • Stott, CG, White, L, Wright, S, et al. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray. Eur J Clin Pharmacol. 2013;69(4):825–834. doi: 10.1007/s00228-012-1393-4
  • Oh, DA, Parikh, N, Khurana, V, et al. Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers. Clin Pharmacol. 2017;9:9–17. doi: 10.2147/CPAA.S119676
  • Lunn, S, Diaz, P, O’Hearn, S, et al. Human pharmacokinetic parameters of orally administered delta(9)-tetrahydrocannabinol capsules are altered by fed versus fasted conditions and sex differences. Cannabis Cannabinoid Res. 2019;4(4):255–264. doi: 10.1089/can.2019.0037
  • Taylor, L, Gidal, B, Blakey, G, et al. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32(11):1053–1067. doi: 10.1007/s40263-018-0578-5
  • Crockett, J, Critchley, D, Tayo, B, et al. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects. Epilepsia. 2020;61(2):267–277. doi: 10.1111/epi.16419
  • Micklewright, D. The effect of soft tissue release on delayed onset muscle soreness: a pilot study. Phys Ther Sport. 2009 Feb;10(1):19–24. doi: 10.1016/j.ptsp.2008.09.003
  • Thanawala, S, Shah, R, Karlapudi, V, et al. Efficacy and safety of TurmXTRA® 60N in delayed onset muscle soreness in healthy, recreationally active subjects: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2022 Aug 5;2022:9110414. doi: 10.1155/2022/9110414.
  • Cheng, L, Wang, K, He, B, et al. Effect of vertical vibration stimulation at different frequencies on delayed muscle soreness in athletes: a randomized trial. Front Public Health. 2022 Oct 14;10:980454. doi: 10.3389/fpubh.2022.980454
  • Que, N. Effect of kinesio taping in combination with vibration treatment on college students’ delayed-onset muscle soreness. Front Physiol. 2023 Jan 25;14:1058637. doi: 10.3389/fphys.2023.1058637
  • Fischer, AA. Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold. Pain. 1987 Jul;30(1):115–126. doi: 10.1016/0304-3959(87)90089-3
  • Park, G, Kim, CW, Park, SB, et al. Reliability and usefulness of the pressure pain threshold measurement in patients with myofascial pain. Ann Rehabil Med. 2011 Jun;35(3):412–417. doi: 10.5535/arm.2011.35.3.412
  • Huang, CC, Lee, MC, Ho, CS, et al. Protective and recovery effects of resveratrol supplementation on exercise performance and muscle damage following acute plyometric exercise. Nutrients. 2021 Sep 16;13(9):3217. doi: 10.3390/nu13093217
  • Fleckenstein, J, Neuberger, EWI, Bormuth, P, et al. Investigation of the sympathetic regulation in delayed onset muscle soreness: results of an RCT. Front Physiol. 2021 Sep 16;12:697335. doi: 10.3389/fphys.2021.697335
  • Kodesh, E, Sirkis-Gork, A, Mankovsky-Arnold, T, et al. Susceptibility to movement-evoked pain following resistance exercise. PLoS One. 2022 Jul 21;17(7):e0271336. doi: 10.1371/journal.pone.0271336
  • Ma, F, Li, Y, Chen, Q, et al. Effects of photobiomodulation and low-intensity stretching on delayed-onset muscle soreness: a randomized control trial. Photobiomodul Photomed Laser Surg. 2022 Dec;40(12):810–817. doi: 10.1089/photob.2022.0055
  • Lenn, J, Uhl, T, Mattacola, C, et al. The effects of fish oil and isoflavones on delayed onset muscle soreness. Med Sci Sports Exerc. 2002 Oct;34(10):1605–1613. doi: 10.1097/00005768-200210000-00012
  • Kraemer, WJ, Bush, JA, Wickham, RB, et al. Influence of compression therapy on symptoms following soft tissue injury from maximal eccentric exercise. J Orthop Sports Phys Ther. 2001 Jun;31(6):282–290. doi: 10.2519/jospt.2001.31.6.282
  • Nosaka, K, Newton, M, Sacco, P. Delayed-onset muscle soreness does not reflect the magnitude of eccentric exercise-induced muscle damage. Scand J Med Sci Sports. 2002 Dec;12(6):337–346. doi: 10.1034/j.1600-0838.2002.10178.x
  • Heuchert, JP, McNair, DM. Profile of mood states. North Tonawanda: Multi-health systems; 2012.
  • Yoshihara, K, Hiramoto, T, Sudo, N, et al. Profile of mood states and stress-related biochemical indices in long-term yoga practitioners. Biopsychosoc Med. 2011;5(1):6. doi: 10.1186/1751-0759-5-6
  • Lv, ZT, Zhang, JM, Zhu, WT. Omega-3 polyunsaturated fatty acid supplementation for reducing muscle soreness after eccentric exercise: a systematic review and meta-analysis of randomized controlled trials. Biomed Res Int. 2020 Apr 20;2020:8062017. doi: 10.1155/2020/8062017
  • Bleakley, C, McDonough, S, Gardner, E, et al. Cold‐water immersion (cryotherapy) for preventing and treating muscle soreness after exercise. Cochrane Database Syst Rev. 2012; 2, Art. No.: CD008262, 10.1002/14651858.CD008262.pub2
  • Goulet-Pelletier, JC, Cousineau, D. A review of effect sizes and their confidence intervals, part I: the cohen’s d family. Quant Meth Psych. 2018;14(4):242–265. doi: 10.20982/tqmp.14.4.p242
  • Lakens, D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Frontiers In Psychology. 2013;4:863. doi: 10.3389/fpsyg.2013.00863
  • Lee, EC, Whitehead, AL, Jacques, RM, et al. The statistical interpretation of pilot trials: should significance thresholds be reconsidered? BMC Med Res Methodol. 2014;14(1):1–8. doi: 10.1186/1471-2288-14-41
  • Tashjian, RZ, Deloach, J, Porucznik, CA, et al. Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. J Shoulder Elbow Surg. 2009;18(6):927–932. doi: 10.1016/j.jse.2009.03.021
  • Katz, N. The impact of pain management on quality of life. J Pain Sympt Manage. 2002;24(1):S38–47. doi: 10.1016/S0885-3924(02)00411-6